Target intelligence / Profile preview

Salmonella enterica serovar Enteritidis O-antigen (SE O-antigen) (SE O-antigen)

Target
SE O-antigen
Molecular classification
Other (Bacterial surface polysaccharide)
01

Overview

Salmonella enterica serovar Enteritidis O-antigen is a complex polysaccharide component of the lipopolysaccharide (LPS) located on the outer membrane of the bacterium. It is composed of repeating tetrasaccharide units consisting of rhamnose, mannose, and galactose, with a characteristic tyvelose side chain that defines the O9 serogroup (Liu et al., 2014). This surface structure plays a vital role in bacterial physiology by maintaining membrane integrity and acting as a protective shield against host defenses, such as the complement system and antimicrobial peptides (Murray et al., 2003). In clinical medicine, Salmonella Enteritidis is a major cause of foodborne illness and invasive salmonellosis, making its O-antigen a primary target for diagnostic assays and prophylactic interventions (NCBI, 2023). Current therapeutic development focuses on glycoconjugate vaccines that link the O-antigen to carrier proteins to elicit a robust T-cell dependent immune response (Micoli et al., 2018). Additionally, monoclonal antibodies targeting specific epitopes of the O-antigen are being investigated for their potential to provide passive immunity and enhance opsonophagocytosis (Simeon et al., 2020).

Other names
Salmonella Enteritidis O-polysaccharideO9 antigenLPS O-side chainSalmonella Group D1 O-antigen
02

Mechanism of action

Induction of protective humoral immunity through the production of opsonophagocytic and bactericidal antibodies targeting the O9 epitope of the bacterial lipopolysaccharide.

03

Biological functions

Immune responseOther (Bacterial pathogenesis)Other (Structural integrity)
04

Disease associations

Infection
05

Safety considerations

Potential endotoxicity from residual Lipid ALimited cross-protection against non-O9 serovarsCarrier protein hypersensitivity
06

Interacting drugs

Salmonella Enteritidis O-antigen conjugate vaccine (Experimental)

2 more in the full profile.

07

Biomarkers

Anti-O9 IgG antibody titersO-antigen polymerase (wzy) expression levelsO-antigen chain length distribution

Beyond the preview

Go deeper on Salmonella enterica serovar Enteritidis O-antigen (SE O-antigen) (SE O-antigen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salmonella enterica serovar Enteritidis O-antigen (SE O-antigen) (SE O-antigen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call